Echo IQ is trading at A$1.57 (-5.12%) on August 13, 2026, with no confirmed company announcement or reliable report identifying a direct catalyst.
- The August 5 FDA 510(k) submission for EchoSolv HF remains relevant investor context but predates the move and does not clearly explain the decline.
- Broader market indicators were broadly flat; trading-volume data was unavailable.